Navigation Links
Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S.
Date:9/23/2010

Factors," to our Quarterly Report on Securities and Exchange Commission Form 10-Q for the period ended March 31, 2010, and are incorporated by reference. Abbott undertakes no obligation to release publicly any revisions to forward-looking statements as a result of subsequent events or developments.


'/>"/>
SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
2. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
3. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
4. Abbotts ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study
5. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
6. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
7. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
8. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
9. Abbotts XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
10. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/x5lz9r/global_poc ) ... Diagnostics Market 2015-2019" report to their offering. ... Diagnostics market to grow at a CAGR of 8.47 ... diagnostics are IVD devices and tools used for diagnosing ... use of these devices helps in the rapid diagnosis ...
(Date:3/3/2015)... , March 3, 2015  Columbia Laboratories, Inc. (Nasdaq: ... or "the Company"), a specialty pharmaceutical company focused on ... present at the 27th Annual ROTH Conference, which will ... Niguel in Dana Point, California . ... at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time) ...
(Date:3/3/2015)... Mar. 03, 2015 Research and Markets ... of the "Global Ultrasound Equipment Market 2015-2019" ... The Global Ultrasound Equipment market to ... period 2014-2019 Ultrasound equipment are used ... systems are extensively used by cardiologists, radiologists, surgeons, ...
Breaking Medicine Technology:Global POC Diagnostics Market 2015-2019 with Abbott Labs, Alere, Bayer Healthcare, Danaher, F. Hoffmann-La Roche & Johnson & Johnson Dominating 2Global Ultrasound Equipment Market 2015-2019: Rise in Number of MI Diagnostic Procedures with GE Healthcare, Phillips Healthcare, Siemens Healthcare & Toshiba Medical Systems Dominating 2
... Md., April 15 MedImmune today announced,that it ... potential treatment,for patients with asthma, with the start ... targeting interleukin-13 (IL-13). One of the,studies is a ... designed to,assess the potential of the anti-IL-13 MAb ...
... Effort utilizes Phreesia,s automated patient check-in system to enable ... better management of ... Inc., the Patient Check-In,Company, has announced that it will ... University Medical Center into its,electronic patient intake process, thereby ...
Cached Medicine Technology:MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13 2MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13 3Phreesia Announces Clinical Initiative to Better Manage Symptoms of Parkinson's Disease 2
(Date:3/3/2015)... Diamond Bar, Calif. (PRWEB) March 03, 2015 ... a leading provider of enterprise Time and Attendance ... has successfully migrated to NOVAtime SaaS Workforce ... automate its time and attendance processes. , ... provide those with developmental disabilities with the best ...
(Date:3/3/2015)... 03, 2015 Today, Steve Weatherford, current ... Seahawks wide receiver, announced the donation of their brains ... Brain Injury Awareness Month. In an effort to raise ... importance of brain health, Rice and Weatherford spoke of ... need to make brain health a priority to avoid ...
(Date:3/3/2015)... SC (PRWEB) March 03, 2015 The ... the public’s expectation of excellence in care and safe ... the position of the RNS that biologic infusions are ... under the direct supervision of a registered nurse (RN), ... reactions, including anaphylaxis can occur in patients receiving these ...
(Date:3/3/2015)... Dr. Michael Nochomovitz has been ... integration and network development officer for the ... role, Dr. Nochomovitz is responsible for the ... enterprise, its integration within NewYork-Presbyterian and collaboration ... , Dr. Nochomovitz brings 17 years of ...
(Date:3/3/2015)... Topical BioMedics, Inc., announces its March Pain Management ... Tuesday, March 10th, 12pm – 1pm and 4pm to 5pm. ... , The Pain Management Workshops are free ... 10th workshop is “Opioid Addiction: An Over-Medicated Society.” ... 5% of the world’s population, yet consumers 99% of the ...
Breaking Medicine News(10 mins):Health News:Innovative Services, Inc. Successfully Migrates to Cloud-Based NOVAtime Workforce Management Solution to Support Growth and Improve Payroll Processing Time 2Health News:Innovative Services, Inc. Successfully Migrates to Cloud-Based NOVAtime Workforce Management Solution to Support Growth and Improve Payroll Processing Time 3Health News:Steve Weatherford and Sidney Rice Reveal Donation for Brain Injury Awareness Month 2Health News:Administration of Biologic Infusions: A Position Statement of the Rheumatology Nurses Society 2Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 2Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 3Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 4Health News:Topical BioMedics Hosts March Pain Management Webinar 2Health News:Topical BioMedics Hosts March Pain Management Webinar 3Health News:Topical BioMedics Hosts March Pain Management Webinar 4Health News:Topical BioMedics Hosts March Pain Management Webinar 5
... have shown that the drug everolimus delays tumor progression ... that affect particular hormone-producing cells. At the 35th ... Dr Marianne Pavel from Charit University in Berlin, Germany ... in patients with advanced neuroendocrine tumors. Neuroendocrine tumors ...
... As the population ages, health care epidemiologist Padma Kaul and ... Dentistry at the University of Alberta, want health-care professionals to ... die, whether it be at home, in hospital or a ... in their recent study, that the majority of heart failure ...
... By Amanda Gardner HealthDay Reporter , MONDAY, Oct. ... at higher risk for stroke even if they don,t have ... to people who show signs of insulin resistance -- a ... glucose from the bloodstream -- may be helpful in preventing ...
... the last six months of life has become progressively more ... in the United States and older adults in Canada, with ... of life in both countries, according to two reports posted ... print issue of Archives of Internal Medicine , one ...
... of Medicare recipients undergoing treatment for retinal conditions nearly ... the types of procedures most commonly performed, according to ... of Ophthalmology , one of the JAMA/Archives journals. ... both age-related macular degeneration (AMD) and diabetic retinopathy account ...
... HealthDay Reporter , MONDAY, Oct. 11 (HealthDay News) -- ... front of the TV or computer were at greater risk ... even if the kids also tended to be physically active, ... and in the November print issue of Pediatrics , ...
Cached Medicine News:Health News:Phase III study shows everolimus delays tumor progression in hard-to-treat neuroendocrine tumors 2Health News:Medical researchers break down costs to care for heart failure patients at the end of life 2Health News:Insulin Resistance Might Raise Risk of Stroke 2Health News:Insulin Resistance Might Raise Risk of Stroke 3Health News:End-of-life care patterns shift for patients with heart failure in both US and Canada 2Health News:End-of-life care patterns shift for patients with heart failure in both US and Canada 3Health News:End-of-life care patterns shift for patients with heart failure in both US and Canada 4Health News:End-of-life care patterns shift for patients with heart failure in both US and Canada 5Health News:Treatment of retinal conditions appears to have changed significantly in previous decade 2Health News:Could Excess Computer, TV Time Harm Kids Psychologically? 2Health News:Could Excess Computer, TV Time Harm Kids Psychologically? 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: